Supplementary Material for: Detailed Assessment of Renal Function in a Proband with Harboyan Syndrome Caused by a Novel Homozygous <b><i>SLC4A11 </i></b>Nonsense Mutation

<b><i>Background/Aims:</i></b> To identify the underlying molecular genetic cause of disease in a patient with Harboyan syndrome and to perform a detailed assessment of her renal function. We also assessed the influence of the <i>SLC4A11</i> mutation identified on the corneal endothelium in the heterozygous state. <b><i>Methods:</i></b> A 55-year-old female was examined ophthalmologically, audiologically and nephrologically including 24-hour urine collection. The coding region of <i>SLC4A11</i> was directly sequenced. Specular microscopy was performed in the proband's 21-year-old daughter. <b><i>Results:</i></b> The proband had bilateral iridectomy at the age of 3 months because of an initial diagnosis of congenital glaucoma and since the age of 12 years she underwent several keratoplasties in each eye. Nephrological examination did not reveal any abnormalities. Moderate bilateral sensorineural hearing loss was confirmed by audiometry. A novel homozygous mutation predicted to lead to a premature stop codon at the protein level, c.2188C>T; p.(Arg730*), was identified in <i>SLC4A11</i>. No changes in corneal endothelial cell morphology or density were observed in the heterozygous daughter. <b><i>Conclusion:</i></b> In contrast to the <i>Slc4a11</i><sup>-/-</sup> mouse, no abnormalities in daily renal ion excretion or polyuria were observed in the Harboyan syndrome patient. The mutation identified does not affect corneal endothelial cell morphology or density in the heterozygous state. © 2014 S. Karger AG, Basel